中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
20期
3051-3053,3054
,共4页
陶红蕾%姜云峰%马婷婷%李国政%彭从斌
陶紅蕾%薑雲峰%馬婷婷%李國政%彭從斌
도홍뢰%강운봉%마정정%리국정%팽종빈
术后认知功能障碍%通窍益脑方%白细胞介素-6
術後認知功能障礙%通纖益腦方%白細胞介素-6
술후인지공능장애%통규익뇌방%백세포개소-6
Postoperative cognitive dysfunction%Tingqiao Yinao decoction%Interleukin-6
目的:探讨“通窍益脑方”对老年患者术后认知功能障碍( POCD)的治疗效果和作用机制。方法选择全身麻醉下行骨科手术患者100例,按随机数字表分为“通窍益脑方”治疗组和对照组,每组50例。对照组常规治疗,不口服中药。治疗组在常规治疗基础上,每天2次口服中药汤剂“通窍益脑方”150 mL,连续服用15 d。采用简易智能状态检查法分别于麻醉前1 d及术后第1、3、7天评估患者认知功能,另于相应时间同时采血样检测患者的IL-6水平。结果两组术前基本情况差异无统计学意义。术后1 d,治疗组和对照组POCD发生率分别为30%和38%;术后3 d,治疗组和对照组POCD发生率分别为28%和20%;术后7 d,治疗组和对照组POCD发生率分别为20%和12%,两组差异有统计学意义(χ2=4.332,P=0.037)。与术前比较,两组术后3 d血清中IL-6含量均显著增加,差异有统计学意义(对照组,t=2.412,P=0.009;治疗组,t=1.429,P=0.039);对照组术后7 d仍高于术前水平(t=0.851,P=0.049);但是治疗组术后7 d已基本恢复,与术前差异无统计学意义(P=0.404);与对照组比较,治疗组术后3 d IL-6含量显著降低(t=1.198, P=0.035)。血清IL-6含量变化与MMSE评分负相关(r=-0.782,P=0.022)。结论“通窍益脑方”可有效改善老年患者术后认知功能障碍的症状,推测其作用机制可能与抑制血清中的IL-6有关。
目的:探討“通纖益腦方”對老年患者術後認知功能障礙( POCD)的治療效果和作用機製。方法選擇全身痳醉下行骨科手術患者100例,按隨機數字錶分為“通纖益腦方”治療組和對照組,每組50例。對照組常規治療,不口服中藥。治療組在常規治療基礎上,每天2次口服中藥湯劑“通纖益腦方”150 mL,連續服用15 d。採用簡易智能狀態檢查法分彆于痳醉前1 d及術後第1、3、7天評估患者認知功能,另于相應時間同時採血樣檢測患者的IL-6水平。結果兩組術前基本情況差異無統計學意義。術後1 d,治療組和對照組POCD髮生率分彆為30%和38%;術後3 d,治療組和對照組POCD髮生率分彆為28%和20%;術後7 d,治療組和對照組POCD髮生率分彆為20%和12%,兩組差異有統計學意義(χ2=4.332,P=0.037)。與術前比較,兩組術後3 d血清中IL-6含量均顯著增加,差異有統計學意義(對照組,t=2.412,P=0.009;治療組,t=1.429,P=0.039);對照組術後7 d仍高于術前水平(t=0.851,P=0.049);但是治療組術後7 d已基本恢複,與術前差異無統計學意義(P=0.404);與對照組比較,治療組術後3 d IL-6含量顯著降低(t=1.198, P=0.035)。血清IL-6含量變化與MMSE評分負相關(r=-0.782,P=0.022)。結論“通纖益腦方”可有效改善老年患者術後認知功能障礙的癥狀,推測其作用機製可能與抑製血清中的IL-6有關。
목적:탐토“통규익뇌방”대노년환자술후인지공능장애( POCD)적치료효과화작용궤제。방법선택전신마취하행골과수술환자100례,안수궤수자표분위“통규익뇌방”치료조화대조조,매조50례。대조조상규치료,불구복중약。치료조재상규치료기출상,매천2차구복중약탕제“통규익뇌방”150 mL,련속복용15 d。채용간역지능상태검사법분별우마취전1 d급술후제1、3、7천평고환자인지공능,령우상응시간동시채혈양검측환자적IL-6수평。결과량조술전기본정황차이무통계학의의。술후1 d,치료조화대조조POCD발생솔분별위30%화38%;술후3 d,치료조화대조조POCD발생솔분별위28%화20%;술후7 d,치료조화대조조POCD발생솔분별위20%화12%,량조차이유통계학의의(χ2=4.332,P=0.037)。여술전비교,량조술후3 d혈청중IL-6함량균현저증가,차이유통계학의의(대조조,t=2.412,P=0.009;치료조,t=1.429,P=0.039);대조조술후7 d잉고우술전수평(t=0.851,P=0.049);단시치료조술후7 d이기본회복,여술전차이무통계학의의(P=0.404);여대조조비교,치료조술후3 d IL-6함량현저강저(t=1.198, P=0.035)。혈청IL-6함량변화여MMSE평분부상관(r=-0.782,P=0.022)。결론“통규익뇌방”가유효개선노년환자술후인지공능장애적증상,추측기작용궤제가능여억제혈청중적IL-6유관。
Objective To investigate the effect of Tongqiao Yinao decoction ( TYD) on postoperative cogni-tive dysfunction in elderly patients and its underlying mechanisms .Methods 100 anesthetic patients for orthopedic surgery were randomly divided into the TYD-treated group and control group ,50 patients in each group .In TYD-trea-ted group,patients received 150mL TYD orally,twice daily for constitutive 15 days,beginning from the day of admis-sion in addition to conventional symptomatic and supportive treatment .While patients in control group received no TYD.Mini-mental state examination ( MMSE) was used to evaluate the patients′cognitive function before and after anesthesia.Meanwhile,blood samples of patients were also collected to test the expression levels of IL -6.Results There was no significant difference between the two groups before operation .However ,TYD-treated patients had signif-icantly lower incidence rate of POCD than the controls ( 20% in the control group , and 12% in the TYD-treated group;χ2 =4.332,P=0.037) 7 days after operation.The incidence rates of POCD in the TYD-treated group and control group were 30%and 38%1 day after operation ( P>0.05),28% and 20% 3 days after operation ( P>0.05),respectively.Compared with that before operation ,the blood levels of IL-6 in the two groups significantly increased 3 days after operation (control group,t=2.412,P=0.009;TYD-treated group,t=1.429,P=0.039).In contrast to the control group,the level of IL-6 in TYD-treated group declined to the baseline (the control group,t=0.851,P=0.049;TYD-treated group,P=0.404).Interestingly,compared with the controls,the TYD-treated patients had a significant lower level of IL-6 after operation (t=1.198,P=0.035).Furthermore,Pearson correlation analysis showed that change of IL-6 level in blood was negatively correlated with MMSE score (r=-0.782,P=0.022). Conclusion TYD can improve postoperative cognitive dysfunction in elderly patients ,presumably through decreasing the level of IL-6 in blood.